- Home
- BMRN vs BEP Comparison
BMRN vs BEP Comparison
Compare BMRN & BEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMRN | BEP |
|---|---|---|
| Founded | 1996 | 1999 |
| Country | United States | Canada |
| Employees | N/A | 5870 |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 10.3B |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | BMRN | BEP |
|---|---|---|
| Price | $49.61 | $34.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 10 |
| Target Price | ★ $88.22 | $35.70 |
| AVG Volume (30 Days) | ★ 1.7M | 945.8K |
| Earning Date | 05-04-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 4.71% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $1,313,646,000.00 | N/A |
| Revenue This Year | $15.02 | $17.09 |
| Revenue Next Year | $12.23 | N/A |
| P/E Ratio | $95.96 | ★ N/A |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $50.76 | $22.64 |
| 52 Week High | $66.28 | $35.97 |
Technical Indicators
Market Signals| Indicator | BMRN | BEP |
|---|---|---|
| Relative Strength Index (RSI) | 31.83 | 54.48 |
| Support Level | N/A | $32.05 |
| Resistance Level | $56.91 | $35.44 |
| Average True Range (ATR) | 1.85 | 1.12 |
| MACD | -0.25 | -0.01 |
| Stochastic Oscillator | 4.96 | 78.64 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About BEP Brookfield Renewable Partners L.P.
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners and Brookfield Renewable Corp.